Finerenone shows positive results for kidney disease in T1D – Breakthrough T1D

Written by

admin

in

  1. Finerenone shows positive results for kidney disease in T1D  Breakthrough T1D
  2. Kerendia® (finerenone) meets primary endpoint in phase III clinical trial for adults with type 1 diabetes and chronic kidney disease  MarketScreener
  3. Kidney drug trial raises hopes for new type 1 diabetes treatment  upi.com
  4. Bayer (BAYRY) reports Kerendia met Phase III goal; 25% UACR cut in T1D CKD trial  Stock Titan
  5. Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation  Nature

Continue Reading

More posts